N@N

Myriad Genetics: Myriad Genetics to Report Fiscal 2009 Third Quarter Financial Results on May 4

^{Published on 2009-04-15 13:18:42, Last Modified on 2009-04-15 13:19:09 - Market Wire}
 

SALT LAKE CITY, UT--(Marketwire - April 15, 2009) - Myriad Genetics, Inc. (NASDAQ: [ MYGN ]) today announced that it will release its fiscal 2009 third quarter financial results at the close of market on Monday, May 4, 2009.

The company will host a conference call on Tuesday, May 5, at 10:00 a.m. Eastern to review the financial results. Participating on the call will be: Peter D. Meldrum, President and Chief Executive Officer; Jim Evans, Chief Financial Officer; Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc.; and, Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

To participate on the call, callers may dial (212) 231-2903 or (800) 768-5109 approximately 10-15 minutes before the start of the call. All callers will be asked to reference reservation number 21421979.

The conference call also will be available to interested parties through a live audio Internet broadcast at [ www.myriad.com ].

A replay of the call will be available beginning two hours after the end of the call until seven days following the call and may be accessed by dialing (800) 633-8284 or (402) 977-9140, and entering the reservation number 21421979.

Myriad Genetics, Inc. is a leading healthcare company focused on the development and marketing of novel molecular diagnostic and therapeutic products. Myriad's news and other information are available on the company's Web site at [ www.myriad.com ]. MYGN-F